Neurology · 2002 · 598 citations · 9 references
Life SciencesNeurologyNeuroscienceClinical NeuroscienceNeuroimmunologyNeurologic PharmacotherapyDemyelinating DiseasesDemyelinating DisordersMultiple SclerosisFunctional ImprovementRelapsing Demyelinating DiseaseRelapsing-remitting Multiple Sclerosis TreatmentTherapeutic Plasma Exchange
Most patients had relapsing‑remitting MS (37.3 %), neuromyelitis optica (16.9 %), or acute disseminated encephalomyelitis (16.9 %). The authors reviewed 59 consecutive patients treated with plasma exchange for acute, severe attacks of CNS demyelination at Mayo Clinic from January 1984 through June 2000. PE led to moderate or marked functional improvement in 44.1 % of patients, with male sex, preserved reflexes, and early treatment initiation predicting better outcomes, and the gains were rapid and sustained.
The authors reviewed 59 consecutive patients treated with plasma exchange (PE) for acute, severe attacks of CNS demyelination at Mayo Clinic from January 1984 through June 2000. Most patients had relapsing-remitting MS (n = 22, 37.3%), neuromyelitis optica (NMO) (n = 10, 16.9%), and acute disseminated encephalomyelitis (n = 10, 16.9%). PE was followed by moderate or marked functional improvement in 44.1% of treated patients. Male sex (<i><i>p</i></i> = 0.021), preserved reflexes (<i>p</i> = 0.019), and early initiation of treatment (<i>p</i> = 0.009) were associated with moderate or marked improvement. Successfully treated patients improved rapidly following PE, and improvement was sustained.
9
Rating neurologic impairment in multiple sclerosis
John F. Kurtzke · Neurology · 1983 · 14.9K citations
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Charles M. Poser, Donald W. Paty, Labe C. Scheinberg et al. · Annals of Neurology · 1983 · 7.4K citations
The clinical course of neuromyelitis optica (Devic’s syndrome)
Dean M. Wingerchuk, William F. Hogancamp, Peter C. O’Brien et al. · Neurology · 1999 · 1.8K citations
Medicine, Neurology, Neuroscience +12